# Nuevolution A/S

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nuevolution-a-s

- Industry: Pharmaceuticals
- Headquarters: Copenhagen, Denmark
- Website: www.nuevolution.com
- Total disclosed funding: $20M
- Latest round: Series B (Oct 9, 2003)
- Investors on record: 5

## About

Founded in 2001 and based in Copenhagen, Denmark, Nuevolution A/S operates as a biopharmaceutical company which develops Chemetics®, a technology for small molecule lead discovery applications. The company focuses on developing treatment within oncology and chronic inflammatory diseases.

## Funding rounds

- Series B, Oct 9, 2003, $15M — Dansk Vækstkapital, NB Capital, SLS Invest, Novo Holdings, SEB Asset Management
- Series A, Dec 3, 2001, $4.8M — Dansk Vækstkapital, NB Capital, Novo Holdings

## Investors

- Dansk Vækstkapital — Series A, Series B
- NB Capital (https://capitalatlas.ai/funds/nb-capital) — Series A, Series B
- Novo Holdings — Series A, Series B
- SLS Invest (https://capitalatlas.ai/funds/sls-invest) — Series B
- SEB Asset Management (https://capitalatlas.ai/funds/seb-asset-management) — Series B
